Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

GBS Inc. (GBS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7900+0.1100 (+6.55%)
At close: 04:00PM EST
1.7900 0.00 (0.00%)
After hours: 07:23PM EST
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study

    NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced it will commence preparation for clinical trials of its rapid SARS-CoV-2 Antibody test following the recent successful completion of a clinical validation study. As previously referenced, a clinical validation study was conducted at the Wyss Institute for Biologically

  • GlobeNewswire

    GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights

    – Announced Pre-Submission Package sent to the FDA for its Glucose Biosensor Test – – Clinical Validation Study Results for SARS CoV2 Ab Test – – Evaluating site locations for build out of high-tech manufacturing facility supported by $4.7 Million Grant Funding from Australian Government – – $12.6 Million in Cash, Cash Equivalents, and Marketable Securities as of September 30, 2021, Provides Estimated Runway into H1 2023 – – To Host Conference Call and Webcast Today at 4:30 p.m. ET – NEW YORK, N

  • GlobeNewswire

    GBS Inc. to Present First Quarter 2022 Financial Results and Recent Corporate Update on November 11

    Company to Host Conference Call & Webcast at 4:30 p.m. ETNEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the first quarter ended September 30, 2021, shortly after the NASDAQ market close on Thursday, November 11. Management will then host a conference call and webcast

Advertisement
Advertisement